Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PAUL D LYONS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Clinical Neurophysiology

NPI
1083656250
CMS profile
4126
Location
WINCHESTER, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$30,100.89

216 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PAUL D LYONS

NPI 1083656250 · CMS profile ID 4126

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Clinical Neurophysiology

WINCHESTER, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1083656250?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PAUL D LYONS, NPI 1083656250, CMS profile ID 4126. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1083656250?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). PAUL D LYONS, NPI 1083656250, CMS profile ID 4126. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1083656250?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
PAUL D LYONS, NPI 1083656250, CMS profile ID 4126, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1083656250?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

216 matching records · $30,100.89 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 216 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 216.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
SK Life Science, Inc. $31.8910/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154110723 CMS
UCB, Inc. $7.8410/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143210797 CMS
UCB, Inc. $40.0010/08/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143210801 CMS
Lundbeck LLC $24.8910/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145941178 CMS
Eisai Inc. $0.5710/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110772001 CMS
Eisai Inc. $26.3410/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110772003 CMS
MITSUBISHI TANABE PHARMA AMERICA, INC. $20.1910/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144511991 CMS
Lundbeck LLC $11.9910/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145941176 CMS
PFIZER INC. $7.2310/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1130875874 CMS
UCB, Inc. $36.1610/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143210793 CMS
Inspire Medical Systems, Inc. $29.6809/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148075937 CMS
PFIZER INC. $18.7209/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131994735 CMS
PFIZER INC. $1.1709/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132065381 CMS
UCB, Inc. $3,400.0009/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143210788 CMS
LivaNova USA, Inc. $24.2609/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152790903 CMS
AstraZeneca Pharmaceuticals LP $14.2109/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105645382 CMS
JAZZ PHARMACEUTICALS INC. $33.0009/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150198539 CMS
ANI Pharmaceuticals, Inc. $30.9009/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091142788 CMS
ARGENX US, INC. $20.0909/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142122256 CMS
ABBVIE INC. $12.9609/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104916577 CMS
JAZZ PHARMACEUTICALS INC. $4,410.0009/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150198545 CMS
Lilly USA, LLC $14.1809/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135319293 CMS
UCB, Inc. $45.0509/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143210784 CMS
ABBVIE INC. $20.9909/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104916575 CMS
Mallinckrodt Hospital Products Inc. $34.5809/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145101712 CMS
UCB, Inc. $121.9509/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143210775 CMS
UCB, Inc. $1,480.5909/03/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143210779 CMS
JAZZ PHARMACEUTICALS INC. $1,694.3708/30/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150198523 CMS
JAZZ PHARMACEUTICALS INC. $124.9908/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150198521 CMS
UCB, Inc. $9.4508/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143210771 CMS
Amneal Pharmaceuticals LLC $15.8308/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139193876 CMS
Alexion Pharmaceuticals, Inc. $19.5408/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094014085 CMS
JAZZ PHARMACEUTICALS INC. $18.9508/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150198535 CMS
PFIZER INC. $0.2508/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132057675 CMS
PFIZER INC. $0.6208/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132057678 CMS
UCB, Inc. $35.0008/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143210767 CMS
PFIZER INC. $13.3208/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131895662 CMS
UCB, Inc. $40.0008/19/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143210762 CMS
Lilly USA, LLC $17.5608/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135275091 CMS
Microtransponder, Inc. $138.8008/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1082717572 CMS
SK Life Science, Inc. $19.0208/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154110701 CMS
Eisai Inc. $0.2508/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110772011 CMS
Eisai Inc. $13.8308/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110772015 CMS
CATALYST PHARMACEUTICALS, INC. $16.7207/26/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144452231 CMS
Eisai Inc. $0.1907/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110772013 CMS
Eisai Inc. $8.9107/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110772005 CMS
PFIZER INC. $0.5007/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132070071 CMS
PFIZER INC. $13.7607/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131741684 CMS
EMD Serono, Inc. $23.8807/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120250989 CMS
UCB, Inc. $5.7707/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143210758 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $28,933.30 188
PY2020 $28,268.11 98
PY2021 $23,665.38 109
PY2022 $24,198.68 166
PY2023 $21,167.34 212
PY2024 $30,100.89 216
PY2025 $15,099.93 152

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $85,422.66 28
PY2024 Principal investigator $32,085.22 24
PY2023 Principal investigator $55,416.19 23
PY2022 Principal investigator $16,486.76 10
PY2021 Principal investigator $32,409.75 9
PY2020 Principal investigator $50,753.47 10
PY2019 Principal investigator $261,287.22 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

28 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $3,750.00 12/24/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295030
Principal investigator 1 Janssen Research & Development, LLC $2,275.00 12/17/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295011
Principal investigator 1 SK Life Science, Inc. $2,500.00 12/02/2025 Non-covered Recipient Entity
VALLEY HEALTH SYSTEMS
YKP3089C049 No dispute reported 06/30/2026 1252274997
Principal investigator 1 SK Life Science, Inc. $500.00 12/02/2025 Non-covered Recipient Entity
VALLEY HEALTH SYSTEMS
YKP3089C049 No dispute reported 06/30/2026 1252274999
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $50.00 11/26/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745766
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $563.35 11/26/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745770
Principal investigator 1 Janssen Research & Development, LLC $6,200.00 11/14/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295151
Principal investigator 1 Janssen Research & Development, LLC $600.00 10/20/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295064
Principal investigator 1 Janssen Research & Development, LLC $1,000.00 10/06/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295073
Principal investigator 1 UCB SA $6,500.00 09/24/2025 Non-covered Recipient Entity
Valley Health Diabetes Management Program
An open-label, multicenter, outpatient extension study to evaluate the safety and tolerability of Staccato alprazolam in STUDY participants 12 years of age and older with stereotypical prolonged seizures No dispute reported 06/30/2026 1246658240
Principal investigator 1 UCB SA $6,500.00 09/22/2025 Non-covered Recipient Entity
Valley Health Diabetes Management Program
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, OUTPATIENT, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF STACCATO ALPRAZOLAM IN STUDY PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH STEREOTYPICAL PROLONGED SEIZURES No dispute reported 06/30/2026 1246658238
Principal investigator 1 Janssen Research & Development, LLC $7,525.00 09/19/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295167
Principal investigator 1 SK Life Science, Inc. $850.00 09/09/2025 Non-covered Recipient Entity
VALLEY HEALTH SYSTEMS
YKP3089C049 No dispute reported 06/30/2026 1252274995
Principal investigator 1 Janssen Research & Development, LLC $1,168.00 09/03/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295182
Principal investigator 1 Janssen Research & Development, LLC $4,950.00 07/28/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295160
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $563.35 07/23/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745774
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $400.00 07/07/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745768
Principal investigator 1 UCB SA $5,593.79 06/16/2025 Non-covered Recipient Entity
WINCHESTER NEUROLOGICAL CONSULTANTS
An open-label, multicenter, outpatient extension study to evaluate the safety and tolerability of Staccato alprazolam in STUDY participants 12 years of age and older with stereotypical prolonged seizures No dispute reported 06/30/2026 1246658246
Principal investigator 1 UCB SA $145.89 06/16/2025 Non-covered Recipient Entity
WINCHESTER NEUROLOGICAL CONSULTANTS
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, OUTPATIENT, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF STACCATO ALPRAZOLAM IN STUDY PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH STEREOTYPICAL PROLONGED SEIZURES No dispute reported 06/30/2026 1246658996
Principal investigator 1 Janssen Research & Development, LLC $4,975.00 06/13/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295140
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,322.68 05/21/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745776
Principal investigator 1 Janssen Research & Development, LLC $3,750.00 05/16/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295038
Principal investigator 1 Janssen Research & Development, LLC $1,875.00 03/19/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295196
Principal investigator 1 Janssen Research & Development, LLC $1,560.00 02/19/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175295099
Principal investigator 1 SK Life Science, Inc. $8,475.00 02/18/2025 Non-covered Recipient Entity
VALLEY HEALTH SYSTEMS
YKP3089C049 No dispute reported 06/30/2026 1252274993
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $3,651.00 01/30/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745772
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,339.60 01/30/2025 Non-covered Recipient Entity
Valley Health System
A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution No dispute reported 06/30/2026 1233745778
Principal investigator 1 Janssen Research & Development, LLC $6,840.00 01/17/2025 Non-covered Recipient Entity
Vly Health-Winchester
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) No dispute reported 06/30/2026 1175294986